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Cocaine DISC1 Co-morbidity Drug abuse Psychiatric disorders a b s t r a c t Substance abuse and other psychiatric diseases may share molecular pathology. In order to test this hypothesis, we examined the role of Disrupted In Schizophrenia 1 (DISC1), a psychiatric risk factor, in cocaine self-administration (SA). Cocaine SA significantly increased expression of DISC1 in the nucleus accumbens (NAc); while knockdown of DISC1 in NAc significantly increased cocaine SA and decreased phosphorylation of GSK-3␤ at Ser9 compared to scrambled shRNA. Our study provides the first mechanistic evidence of a critical role of DISC1 in drug-induced behavioral neuroadaptations and sheds more light at the shared molecular pathology of drug abuse and other major psychiatric disorders.
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Recent studies have made significant progress in uncovering molecular mechanisms of substance abuse. While the majority of studies have concentrated on dopamine (DA)-and glutamate synaptic neurotransmission (Bonci et al., 2003; Kalivas and Volkow, 2011) , there have been fewer studies of the molecular factors involved in neuroplasticity associated with drug addiction (Russo et al., 2009) . As the role of neuroplasticity in mental diseases is being increasingly appreciated (Costa et al., 2001; Penzes et al., 2011) , evaluating contributions of psychiatric genetic risk factors to drug-induced neuroadaptation not only advances our knowledge of the molecular pathology of addiction, but also facilitates studies of molecular mechanisms of co-morbidity between substance abuse and other psychiatric disorders (Volkow, 2009) .
Disrupted In Schizophrenia 1 (DISC1) is a gene disrupted by a balanced (1:11) (q42.1; q14.3) translocation, segregating in the Scottish family with schizophrenia, depression, bipolar disorder and other minor psychiatric conditions (Millar et al., 2000, 
